Ironwood Pharmaceuticals, Inc. (IRWD) — Stock Score Summary

Ironwood Pharmaceuticals, Inc. (IRWD) has a MoatMap StockRank of 99/100 based on Quality (67/100), Value (72/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY. Ironwood Pharmaceuticals operates in the Healthcare sector, which is subject to the 'Healthcare Technology & Resilience' theme (medium conviction). While pharmaceutical companies with robust R&D pipelines can be beneficiaries, there is no specific intelligence to suggest Ironwood presents an asymmetric opportunity within this theme that is unpriced by the market. The link is generic (it's a pharma company), and it's unclear if Ironwood possesses the specific quality compounder attributes (e.g., truly un-copyable moats beyond standard patents, high ROIC from asset-light operations, significant technological innovation beyond basic drug development) that would qualify it for high conviction, especially given the medium conviction level of the theme itself.

Ironwood Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for gastrointestinal (GI) diseases. The company's flagship product, LINZESS/CONSTESS, is a market leader for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Ironwood's competitive edge is derived from its proven commercialization capabilities, a pipeline of novel GI candidates, and strategic collaborations that broaden its reach in this underserved therapeutic area.

Key Financial Metrics

Price$3.92
Market Cap$645M
P/E (TTM)5.92
P/E (Forward)2.55
Price/Book-2.78
Return on Invested Capital66.4%
Gross Margin75.2%
Operating Margin68.1%
Revenue Growth158.9%
Free Cash Flow$51M

Ironwood Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Ironwood Pharmaceuticals, Inc.’s (IRWD) StockRank?
MoatMap’s StockRank for Ironwood Pharmaceuticals, Inc. (IRWD) is 99/100, with a Strong Buy signal. It is a composite of Quality (67), Value (72), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ironwood Pharmaceuticals, Inc. have an economic moat?
Ironwood Pharmaceuticals, Inc. (IRWD) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ironwood Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Ironwood Pharmaceuticals, Inc. (IRWD) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ironwood Pharmaceuticals, Inc. in?
Ironwood Pharmaceuticals, Inc. (IRWD) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksIRWD deep dive reportAI ChampionsHow we score stocksSense-check another stock